|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PALOMAR MEDICAL TECHNOLOGIES INC, 8-K, 1999-12-16 |
Next: DREYFUS PREMIER INTERNATIONAL GROWTH FUND INC, 497, 1999-12-16 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 16, 1999
| Palomar Medical Technologies, Inc. |
| (Exact Name of Registrant as Specified in Charter) |
|
Delaware |
001-11177 |
04-3128178 | ||
| (State or Other Jurisdiction
of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
|
82 Cambridge St., |
Burlington, Massachusetts |
01803 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
|
781-993-2300 |
|
Registrant's telephone number, including area code |
|
(Former Name or Former Address, if Changed Since Last Report) |
Item 5. Other Events.
Effective as of December 8, 1999, Palomar Medical Technologies, Inc. (the "Company") has amended and restated its Bylaws, which are attached hereto and incorporated herein in their entirety.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
| 3.1 | Amended and Restated Bylaws of the Company, effective as of December 8, 1999. |
|
SIGNATURES |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
PALOMAR MEDICAL TECHNOLOGIES, INC. | ||
| Date: December 16, 1999
|
By:
Name: Title: |
Louis P. Valente President and Chief Executive Officer | |
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
3.1 |
Amended and Restated Bylaws of the Company, effective as of December 8, 1999. |
|
|